A 48-year-old woman with a 3-month history of peptic ulcer disease is prescribed ranitidine 300 mg at night. After 6 weeks of therapy, her symptoms improve significantly. However, she develops gynecomastia and sexual dysfunction. She is concerned about continuing the medication. Which of the following is the most appropriate next step in management?